Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(2-(2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile
2. Lgd-4033
1. 1165910-22-4
2. Lgd-4033
3. Ligandrol
4. Lgd4033
5. Vk-5211
6. 4-[(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile
7. 1ejt54415a
8. 4-[(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile
9. Unii-1ejt54415a
10. 4-((2r)-2-((1r)-2,2,2-trifluoro-1-hydroxyethyl)-1-pyrrolidinyl)-2-(trifluoromethyl)benzonitrile
11. 4-{(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl}-2-(trifluoromethyl)benzonitrile
12. Benzonitrile, 4-((2r)-2-((1r)-2,2,2-trifluoro-1-hydroxyethyl)-1-pyrrolidinyl)-2-(trifluoromethyl)-
13. Benzonitrile, 4-[(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)-
14. Ligandrol;lgd-4033
15. Schembl221159
16. Ligandrol [nflis-drug]
17. Lgd4033(lg)
18. Vk5211
19. Dtxsid10657620
20. Ex-a729
21. Bcp07128
22. Lgd-4033lgd-4033
23. Mfcd27923016
24. S8822
25. Zinc95830588
26. Akos022173564
27. Cs-4667
28. Db13934
29. Lgd-4033(vk-5211)
30. Ac-30218
31. Hy-13981
32. A14346
33. J-690039
34. Q21098841
| Molecular Weight | 338.25 g/mol |
|---|---|
| Molecular Formula | C14H12F6N2O |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 2 |
| Exact Mass | 338.08538198 g/mol |
| Monoisotopic Mass | 338.08538198 g/mol |
| Topological Polar Surface Area | 47.3 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 468 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ligandrol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ligandrol, including repackagers and relabelers. The FDA regulates Ligandrol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ligandrol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ligandrol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ligandrol supplier is an individual or a company that provides Ligandrol active pharmaceutical ingredient (API) or Ligandrol finished formulations upon request. The Ligandrol suppliers may include Ligandrol API manufacturers, exporters, distributors and traders.
click here to find a list of Ligandrol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ligandrol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ligandrol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ligandrol GMP manufacturer or Ligandrol GMP API supplier for your needs.
A Ligandrol CoA (Certificate of Analysis) is a formal document that attests to Ligandrol's compliance with Ligandrol specifications and serves as a tool for batch-level quality control.
Ligandrol CoA mostly includes findings from lab analyses of a specific batch. For each Ligandrol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ligandrol may be tested according to a variety of international standards, such as European Pharmacopoeia (Ligandrol EP), Ligandrol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ligandrol USP).
LOOKING FOR A SUPPLIER?
